openPR Logo
Press release

Dhorse shines and sets sail, breaking through innovative future

04-23-2024 08:44 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Dhorse shines and sets sail, breaking through innovative future

Over the past month, Dhorse has attracted a significant number of users through continuous online and offline roadshows. The Dhorse community has grown by 30,000 people, surpassing a total of 50,000. Additionally, Dhorse has secured numerous institutional partnerships and investments, including ChainUP and AC Capital, providing substantial support for its development.

Image: https://www.abnewswire.com/uploads/b417a5a06fe2fd935c8e5a8ce5f38672.jpg

Especially noteworthy was Dhorse's recent presence at the Token2049 conference, showcasing significant momentum. As one of the world's premier blockchain and cryptocurrency events, TOKEN2049 took place in Dubai, serving as one of Asia's largest cryptocurrency and blockchain technology summits. TOKEN2049 brought together professionals, entrepreneurs, investors, and enthusiasts from around the globe, providing a platform for exchange and collaboration.

As a groundbreaking AI project, Dhorse holds lofty ideals in driving the development of the cryptocurrency and blockchain industries, representing the shared aspirations of all cryptocurrency professionals. At the conference, Dhorse exhibited its latest blockchain projects and technology, engaging in discussions with industry leaders and peers regarding collaboration opportunities.

During the presentation, Dhorse's development concepts immediately caught the attention of several investment institutions, serving as a powerful catalyst for its ongoing development. With these investments, Dhorse has gained increased financial support to vigorously pursue technological research and community improvement.

In the five days following the conference, Dhorse achieved several breakthroughs in technology, enriching the entire AI ecosystem with greater intelligence and richness. Simultaneously, Dhorse's visibility has surged, attracting a wave of new users to the community and enhancing its vibrancy. These developments ensure Dhorse's continued smooth development in the future.

As cryptocurrency and blockchain technology continue to evolve, TOKEN2049 has become an essential event for global professionals. In the future, Dhorse will actively participate, collaborating with industry leaders and peers to explore the future direction of the industry, seek new partnership opportunities, and propel the cryptocurrency and blockchain industry to new heights.

Currently, Dhorse is upgrading the underlying logic of its AI through training, aiming to maintain a competitive edge in the AI field. In the future, Dhorse will apply AI to multiple domains, advancing global intelligence and jointly creating a bright future for the cryptocurrency and blockchain industry.

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: Carlyle Investment Group
Contact Person: Dr. Maximilian von Kassel
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=dhorse-shines-and-sets-sail-breaking-through-innovative-future]
Country: United States
Website: https://dhorse.org/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dhorse shines and sets sail, breaking through innovative future here

News-ID: 3473965 • Views:

More Releases from ABNewswire

How to Pick the Best Online Chemistry Tutoring Platform
How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject. Essential Platform Features for Effective Online Chemistry Tutoring Modern chemistry tutoring
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our

All 5 Releases